This inventor holds 1 USPTO granted patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 264 
Years Active: 2022
Title: Jung Hong Jeong: Innovator in Cancer Treatment
Introduction
Jung Hong Jeong is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
One of his key patents is titled "Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same." This invention focuses on an anti-MSLN antibody that exhibits high affinity and specificity for MSLN, making it a promising candidate for effective cancer prevention and treatment. Jung holds 1 patent related to this groundbreaking work.
Career Highlights
Throughout his career, Jung Hong Jeong has worked with reputable organizations, including the Green Cross Corporation and the Mogam Institute for Biomedical Research. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Jung has collaborated with esteemed colleagues such as Yang Mi Lim and Ki Su Kim. Their combined expertise has further enhanced the impact of his research in the biomedical field.
Conclusion
Jung Hong Jeong's contributions to cancer treatment through his patented inventions highlight his role as a significant innovator in the medical field. His work continues to pave the way for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile